Skip to main content

Coronavirus: International Cooperation

Question for Foreign, Commonwealth and Development Office

UIN HL10235, tabled on 11 November 2020

To ask Her Majesty's Government, further to the Written Answer by Baroness Sugg on 6 November (HL9853), what outcomes they expect from their contribution to the COVAX Advance Market Commitment; and how any outcomes will be assessed.

Answered on

25 November 2020

The UK has committed up to £548 million for the COVAX Advance Market Commitment. The UK expects the contribution to support access to COVID-19 vaccines for up to 92 developing countries by contributing to the supply of 1 billion doses in 2021 (subject to vaccines successfully securing stringent regulatory approvals).

FCDO funding agreements with Gavi, the Vaccine Alliance, set out objectives for UK funding, and are subject to rigorous programme management procedures, including routine financial and results reporting, audits, and annual reviews. For multi-donor funded organisations, including Gavi, the UK is an active participant in governance boards and committees, and works with other donors to set objectives, monitor performance, and ensure strong financial management and reporting.